Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 300 shares at $13.25 ($4K) on 2022-11-16, disclosed to the SEC on 2022-11-17.
Open-market sale of $4k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-14 | $375K | — | Filing → |